News
Videos
Conferences
Events
Resources
Subscribe

|Articles|April 22, 2015

Dr. Primo Lara Discusses Emerging Therapies in Kidney Cancer

Primo Neary Lara Jr., associate director of Translational Research at the UC Davis Comprehensive Cancer Center, discusses emerging therapies for patients with kidney cancer.

Primo Neary Lara Jr., associate director of Translational Research and co-leader of the Cancer Therapeutics Program at UC Davis Comprehensive Cancer Center, discusses emerging therapies for patients with kidney cancer.

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Drs. Vogel and Yarchoan

Experts Urge Greater Awareness and Support as Liver Cancer Month Ends

ByDr. Arndt Vogel,Dr. Mark Yarchoan

November 4th 2025

Image of two people.

Pancreatic Cancer on the Rise Among Younger Adults

ByDr. Rosario Ligresti,Dr. Anna Berkenblit

November 3rd 2025

Dr. Dima El-Sharkawi

Understanding Hairy Cell Leukemia: Presentations and Complications

ByDr. Dima El-Sharkawi

November 3rd 2025

For Silvia Davis, a breast cancer diagnosis at the age of 36 led to a fertility preservation journey that resulted in her son, John.

Fertility Preservation During Breast Cancer: ‘I Would Do It All Again’

November 1st 2025

What Are My Options for Liver Cancer Treatment?

ByDr. Anjana Pillai

October 31st 2025

Trending on CURE

Pancreatic Cancer on the Rise Among Younger Adults

FDA Approves Stoboclo and Osenvelt as Biosimilars for Some Cancers

Covering Every FDA Oncology Approval From October 2025

Why ‘There is Hope’ For Patients With Pancreatic Cancer

Experts Urge Greater Awareness and Support as Liver Cancer Month Ends

© 2025 MJH Life Sciences^®

All rights reserved.